ASTRAL
Back to catalog
GLOW Astral research vial

GLOW

GHK-Cu / BPC-157 / TB-500

A three-component preparation of GHK-Cu, BPC-157 and TB-500 in a 50/10/10 mg composition. Supplied as a combined reference preparation for in-vitro cell and extracellular-matrix research.

Mass

  • 50/10/10 mg$87.99In stock

From $87.99Purity ≥99%Third-party tested— View COA

View purchase options

Specifications

GLOW — Specifications
CAS numberBlend
Molecular formulaBlend
FormLyophilized powder
Purity specification≥99%
Net quantity50/10/10 mg / vial

Handling & storage

GLOW — Handling & storage
GuidanceStore lyophilized powder at −20 °C, protected from light. After reconstitution with bacteriostatic water, store at 2–8 °C and use within 30 days. Every vial ships with a batch-specific Certificate of Analysis.
For laboratory research use only. Not a drug, food, cosmetic or supplement. Not for human or veterinary consumption, diagnosis, or treatment.

Documentation

Certificates of Analysis

Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.

Current released record

AST-GLOW-001

Dosage
50/10/10 mg
Purity
Not structured
Laboratory
Janoshik Analytical
Analyzed
2026-07-27
Open source PDF

View the compound COA record →

Related peer-reviewed research

  1. GHK-Cu constituentStimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS letters (1988)
  2. BPC-157 constituentPentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules (Basel, Switzerland) (2014)
  3. Full-length thymosin β4 constituentThymosin beta 4 binds actin in an extended conformation and contacts both the barbed and pointed ends. Biochemistry (1997)